New Mechanisms in Glucose Control

New Mechanisms in Glucose Control presents a clear overviewof the new drugs and treatment therapies that have been developedin recent years to help improve glycaemic management forthe diabetic patient, namely the incretin mimetics (GLP-1 agonists)and DPP-4 inhibitors. It also considers other drug classescurrently in development and undergoing clinical trials includingthe SGLT2 inhibitors and other pipeline products. In addition topharma cotherapeutic agents, the role of bariatric as a managementtool for diabetes is covered as well as consideration of theorganisation of diabetes care with a community focus.
This indispensable pocketbook details the newer treatments andoffers a comparison with more traditional agents includingsulphonyureas, glitazones and insulin. The pros and cons oftraditional therapies are discussed as well as the epidemiology andpathogenesis of type 2 diabetes, helping to give the reader abetter understanding of the disease area and itsmanagement.
New Mechanisms in Glucose Control is essential readingfor health professionals working in primary or secondary care andinvolved in treating diabetic patients.